Misplaced Pages

Iodine, ₅₃I

Iodine
Pronunciation	/ˈaɪədaɪn, -dɪn, -diːn/ ​(EYE-ə-dyne, -⁠din, -⁠deen)
Appearance	lustrous metallic gray solid, black/violet liquid, violet gas
Standard atomic weight Ar°(I)
	126.90447±0.00003 126.90±0.01 (abridged)
Iodine in the periodic table
Hydrogen Helium Lithium Beryllium Boron Carbon Nitrogen Oxygen Fluorine Neon Sodium Magnesium Aluminium Silicon Phosphorus Sulfur Chlorine Argon Potassium Calcium Scandium Titanium Vanadium Chromium Manganese Iron Cobalt Nickel Copper Zinc Gallium Germanium Arsenic Selenium Bromine Krypton Rubidium Strontium Yttrium Zirconium Niobium Molybdenum Technetium Ruthenium Rhodium Palladium Silver Cadmium Indium Tin Antimony Tellurium Iodine Xenon Caesium Barium Lanthanum Cerium Praseodymium Neodymium Promethium Samarium Europium Gadolinium Terbium Dysprosium Holmium Erbium Thulium Ytterbium Lutetium Hafnium Tantalum Tungsten Rhenium Osmium Iridium Platinum Gold Mercury (element) Thallium Lead Bismuth Polonium Astatine Radon Francium Radium Actinium Thorium Protactinium Uranium Neptunium Plutonium Americium Curium Berkelium Californium Einsteinium Fermium Mendelevium Nobelium Lawrencium Rutherfordium Dubnium Seaborgium Bohrium Hassium Meitnerium Darmstadtium Roentgenium Copernicium Nihonium Flerovium Moscovium Livermorium Tennessine Oganesson Br ↑ I ↓ At tellurium ← iodine → xenon
Atomic number (Z)	53
Group	group 17 (halogens)
Period	period 5
Block	p-block
Electron configuration	[Kr] 4d 5s 5p
Electrons per shell	2, 8, 18, 18, 7
Physical properties
Phase at STP	solid
Melting point	(I2) 386.85 K ​(113.7 °C, ​236.66 °F)
Boiling point	(I2) 457.4 K ​(184.3 °C, ​363.7 °F)
Density (at 20° C)	4.944 g/cm
Triple point	386.65 K, ​12.1 kPa
Critical point	819 K, 11.7 MPa
Heat of fusion	(I2) 15.52 kJ/mol
Heat of vaporisation	(I2) 41.57 kJ/mol
Molar heat capacity	(I2) 54.44 J/(mol·K)
Vapour pressure (rhombic) P (Pa) 1 10 100 1 k 10 k 100 k at T (K) 260 282 309 342 381 457
Atomic properties
Oxidation states	common: −1, +1, +3, +5, +7 +2, +4, +6
Electronegativity	Pauling scale: 2.66
Ionisation energies	1st: 1008.4 kJ/mol 2nd: 1845.9 kJ/mol 3rd: 3180 kJ/mol
Atomic radius	empirical: 140 pm
Covalent radius	139±3 pm
Van der Waals radius	198 pm
Spectral lines of iodine
Other properties
Natural occurrence	primordial
Crystal structure	​base-centered orthorhombic (oS8)
Lattice constants	a = 725.79 pm b = 478.28 pm c = 982.38 pm (at 20 °C)
Thermal expansion	74.9×10/K (at 20 °C)
Thermal conductivity	0.449 W/(m⋅K)
Electrical resistivity	1.3×10 Ω⋅m (at 0 °C)
Magnetic ordering	diamagnetic
Molar magnetic susceptibility	−88.7×10 cm/mol (298 K)
Bulk modulus	7.7 GPa
CAS Number	7553-56-2
History
Discovery and first isolation	Bernard Courtois (1811)
Isotopes of iodine v e
Main isotopes Decay abun­dance half-life (t1/2) mode pro­duct I synth 13.2232 h β100% Te I synth 4.1760 d ε Te I synth 59.392 d ε Te I 100% stable I trace 1.614×10 y β Xe I synth 8.0249 d β100% Xe I synth 6.58 h β Xe
Category: Iodine view talk edit | references

Iodine is a chemical element; it has symbol I and atomic number 53. The heaviest of the stable halogens, it exists at standard conditions as a semi-lustrous, non-metallic solid that melts to form a deep violet liquid at 114 °C (237 °F), and boils to a violet gas at 184 °C (363 °F). The element was discovered by the French chemist Bernard Courtois in 1811 and was named two years later by Joseph Louis Gay-Lussac, after the Ancient Greek Ιώδης, meaning 'violet'.

Iodine occurs in many oxidation states, including iodide (I), iodate (IO
₃), and the various periodate anions. As the heaviest essential mineral nutrient, iodine is required for the synthesis of thyroid hormones. Iodine deficiency affects about two billion people and is the leading preventable cause of intellectual disabilities.

The dominant producers of iodine today are Chile and Japan. Due to its high atomic number and ease of attachment to organic compounds, it has also found favour as a non-toxic radiocontrast material. Because of the specificity of its uptake by the human body, radioactive isotopes of iodine can also be used to treat thyroid cancer. Iodine is also used as a catalyst in the industrial production of acetic acid and some polymers.

It is on the World Health Organization's List of Essential Medicines.

History

In 1811, iodine was discovered by French chemist Bernard Courtois, who was born to a family of manufacturers of saltpetre (an essential component of gunpowder). At the time of the Napoleonic Wars, saltpetre was in great demand in France. Saltpetre produced from French nitre beds required sodium carbonate, which could be isolated from seaweed collected on the coasts of Normandy and Brittany. To isolate the sodium carbonate, seaweed was burned and the ash washed with water. The remaining waste was destroyed by adding sulfuric acid. Courtois once added excessive sulfuric acid and a cloud of violet vapour rose. He noted that the vapour crystallised on cold surfaces, making dark black crystals. Courtois suspected that this material was a new element but lacked funding to pursue it further.

Courtois gave samples to his friends, Charles Bernard Desormes (1777–1838) and Nicolas Clément (1779–1841), to continue research. He also gave some of the substance to chemist Joseph Louis Gay-Lussac (1778–1850), and to physicist André-Marie Ampère (1775–1836). On 29 November 1813, Desormes and Clément made Courtois' discovery public by describing the substance to a meeting of the Imperial Institute of France. On 6 December 1813, Gay-Lussac found and announced that the new substance was either an element or a compound of oxygen and he found that it is an element. Gay-Lussac suggested the name "iode" (anglicised as "iodine"), from the Ancient Greek Ιώδης (iodēs, "violet"), because of the colour of iodine vapour. Ampère had given some of his sample to British chemist Humphry Davy (1778–1829), who experimented on the substance and noted its similarity to chlorine and also found it as an element. Davy sent a letter dated 10 December to the Royal Society of London stating that he had identified a new element called iodine. Arguments erupted between Davy and Gay-Lussac over who identified iodine first, but both scientists found that both of them identified iodine first and also knew that Courtois is the first one to isolate the element.

In 1873, the French medical researcher Casimir Davaine (1812–1882) discovered the antiseptic action of iodine. Antonio Grossich (1849–1926), an Istrian-born surgeon, was among the first to use sterilisation of the operative field. In 1908, he introduced tincture of iodine as a way to rapidly sterilise the human skin in the surgical field.

In early periodic tables, iodine was often given the symbol J, for Jod, its name in German; in German texts, J is still frequently used in place of I.

Properties

Iodine is the fourth halogen, being a member of group 17 in the periodic table, below fluorine, chlorine, and bromine; since astatine and tennessine are radioactive, iodine is the heaviest stable halogen. Iodine has an electron configuration of 5s4d5p, with the seven electrons in the fifth and outermost shell being its valence electrons. Like the other halogens, it is one electron short of a full octet and is hence an oxidising agent, reacting with many elements in order to complete its outer shell, although in keeping with periodic trends, it is the weakest oxidising agent among the stable halogens: it has the lowest electronegativity among them, just 2.66 on the Pauling scale (compare fluorine, chlorine, and bromine at 3.98, 3.16, and 2.96 respectively; astatine continues the trend with an electronegativity of 2.2). Elemental iodine hence forms diatomic molecules with chemical formula I₂, where two iodine atoms share a pair of electrons in order to each achieve a stable octet for themselves; at high temperatures, these diatomic molecules reversibly dissociate a pair of iodine atoms. Similarly, the iodide anion, I, is the strongest reducing agent among the stable halogens, being the most easily oxidised back to diatomic I₂. (Astatine goes further, being indeed unstable as At and readily oxidised to At or At.)

The halogens darken in colour as the group is descended: fluorine is a very pale yellow, chlorine is greenish-yellow, bromine is reddish-brown, and iodine is violet.

Elemental iodine is slightly soluble in water, with one gram dissolving in 3450 mL at 20 °C and 1280 mL at 50 °C; potassium iodide may be added to increase solubility via formation of triiodide ions, among other polyiodides. Nonpolar solvents such as hexane and carbon tetrachloride provide a higher solubility. Polar solutions, such as aqueous solutions, are brown, reflecting the role of these solvents as Lewis bases; on the other hand, nonpolar solutions are violet, the color of iodine vapour. Charge-transfer complexes form when iodine is dissolved in polar solvents, hence changing the colour. Iodine is violet when dissolved in carbon tetrachloride and saturated hydrocarbons but deep brown in alcohols and amines, solvents that form charge-transfer adducts.

The melting and boiling points of iodine are the highest among the halogens, conforming to the increasing trend down the group, since iodine has the largest electron cloud among them that is the most easily polarised, resulting in its molecules having the strongest Van der Waals interactions among the halogens. Similarly, iodine is the least volatile of the halogens, though the solid still can be observed to give off purple vapour. Due to this property iodine is commonly used to demonstrate sublimation directly from solid to gas, which gives rise to a misconception that it does not melt in atmospheric pressure. Because it has the largest atomic radius among the halogens, iodine has the lowest first ionisation energy, lowest electron affinity, lowest electronegativity and lowest reactivity of the halogens.

The interhalogen bond in diiodine is the weakest of all the halogens. As such, 1% of a sample of gaseous iodine at atmospheric pressure is dissociated into iodine atoms at 575 °C. Temperatures greater than 750 °C are required for fluorine, chlorine, and bromine to dissociate to a similar extent. Most bonds to iodine are weaker than the analogous bonds to the lighter halogens. Gaseous iodine is composed of I₂ molecules with an I–I bond length of 266.6 pm. The I–I bond is one of the longest single bonds known. It is even longer (271.5 pm) in solid orthorhombic crystalline iodine, which has the same crystal structure as chlorine and bromine. (The record is held by iodine's neighbour xenon: the Xe–Xe bond length is 308.71 pm.) As such, within the iodine molecule, significant electronic interactions occur with the two next-nearest neighbours of each atom, and these interactions give rise, in bulk iodine, to a shiny appearance and semiconducting properties. Iodine is a two-dimensional semiconductor with a band gap of 1.3 eV (125 kJ/mol): it is a semiconductor in the plane of its crystalline layers and an insulator in the perpendicular direction.

Isotopes

Of the forty known isotopes of iodine, only one occurs in nature, iodine-127. The others are radioactive and have half-lives too short to be primordial. As such, iodine is both monoisotopic and mononuclidic and its atomic weight is known to great precision, as it is a constant of nature.

The longest-lived of the radioactive isotopes of iodine is iodine-129, which has a half-life of 15.7 million years, decaying via beta decay to stable xenon-129. Some iodine-129 was formed along with iodine-127 before the formation of the Solar System, but it has by now completely decayed away, making it an extinct radionuclide. Its former presence may be determined from an excess of its daughter xenon-129, but early attempts to use this characteristic to date the supernova source for elements in the Solar System are made difficult by alternative nuclear processes giving iodine-129 and by iodine's volatility at higher temperatures. Due to its mobility in the environment iodine-129 has been used to date very old groundwaters. Traces of iodine-129 still exist today, as it is also a cosmogenic nuclide, formed from cosmic ray spallation of atmospheric xenon: these traces make up 10 to 10 of all terrestrial iodine. It also occurs from open-air nuclear testing, and is not hazardous because of its very long half-life, the longest of all fission products. At the peak of thermonuclear testing in the 1960s and 1970s, iodine-129 still made up only about 10 of all terrestrial iodine. Excited states of iodine-127 and iodine-129 are often used in Mössbauer spectroscopy.

The other iodine radioisotopes have much shorter half-lives, no longer than days. Some of them have medical applications involving the thyroid gland, where the iodine that enters the body is stored and concentrated. Iodine-123 has a half-life of thirteen hours and decays by electron capture to tellurium-123, emitting gamma radiation; it is used in nuclear medicine imaging, including single photon emission computed tomography (SPECT) and X-ray computed tomography (X-Ray CT) scans. Iodine-125 has a half-life of fifty-nine days, decaying by electron capture to tellurium-125 and emitting low-energy gamma radiation; the second-longest-lived iodine radioisotope, it has uses in biological assays, nuclear medicine imaging and in radiation therapy as brachytherapy to treat a number of conditions, including prostate cancer, uveal melanomas, and brain tumours. Finally, iodine-131, with a half-life of eight days, beta decays to an excited state of stable xenon-131 that then converts to the ground state by emitting gamma radiation. It is a common fission product and thus is present in high levels in radioactive fallout. It may then be absorbed through contaminated food, and will also accumulate in the thyroid. As it decays, it may cause damage to the thyroid. The primary risk from exposure to high levels of iodine-131 is the chance occurrence of radiogenic thyroid cancer in later life. Other risks include the possibility of non-cancerous growths and thyroiditis.

Protection usually used against the negative effects of iodine-131 is by saturating the thyroid gland with stable iodine-127 in the form of potassium iodide tablets, taken daily for optimal prophylaxis. However, iodine-131 may also be used for medicinal purposes in radiation therapy for this very reason, when tissue destruction is desired after iodine uptake by the tissue. Iodine-131 is also used as a radioactive tracer.

Chemistry and compounds

Iodine is quite reactive, but it is less so than the lighter halogens, and it is a weaker oxidant. For example, it does not halogenate carbon monoxide, nitric oxide, and sulfur dioxide, which chlorine does. Many metals react with iodine. By the same token, however, since iodine has the lowest ionisation energy among the halogens and is the most easily oxidised of them, it has a more significant cationic chemistry and its higher oxidation states are rather more stable than those of bromine and chlorine, for example in iodine heptafluoride.

Charge-transfer complexes

The iodine molecule, I₂, dissolves in CCl₄ and aliphatic hydrocarbons to give bright violet solutions. In these solvents the absorption band maximum occurs in the 520 – 540 nm region and is assigned to a π to σ transition. When I₂ reacts with Lewis bases in these solvents a blue shift in I₂ peak is seen and the new peak (230 – 330 nm) arises that is due to the formation of adducts, which are referred to as charge-transfer complexes.

Hydrogen iodide

The simplest compound of iodine is hydrogen iodide, HI. It is a colourless gas that reacts with oxygen to give water and iodine. Although it is useful in iodination reactions in the laboratory, it does not have large-scale industrial uses, unlike the other hydrogen halides. Commercially, it is usually made by reacting iodine with hydrogen sulfide or hydrazine:

2 I₂ + N₂H₄ H₂O⟶ 4 HI + N₂

At room temperature, it is a colourless gas, like all of the hydrogen halides except hydrogen fluoride, since hydrogen cannot form strong hydrogen bonds to the large and only mildly electronegative iodine atom. It melts at −51.0 °C (−59.8 °F) and boils at −35.1 °C (−31.2 °F). It is an endothermic compound that can exothermically dissociate at room temperature, although the process is very slow unless a catalyst is present: the reaction between hydrogen and iodine at room temperature to give hydrogen iodide does not proceed to completion. The H–I bond dissociation energy is likewise the smallest of the hydrogen halides, at 295 kJ/mol.

Aqueous hydrogen iodide is known as hydroiodic acid, which is a strong acid. Hydrogen iodide is exceptionally soluble in water: one litre of water will dissolve 425 litres of hydrogen iodide, and the saturated solution has only four water molecules per molecule of hydrogen iodide. Commercial so-called "concentrated" hydroiodic acid usually contains 48–57% HI by mass; the solution forms an azeotrope with boiling point 126.7 °C (260.1 °F) at 56.7 g HI per 100 g solution. Hence hydroiodic acid cannot be concentrated past this point by evaporation of water. Unlike gaseous hydrogen iodide, hydroiodic acid has major industrial use in the manufacture of acetic acid by the Cativa process.

Other binary iodine compounds

With the exception of the noble gases, nearly all elements on the periodic table up to einsteinium (EsI₃ is known) are known to form binary compounds with iodine. Until 1990, nitrogen triiodide was only known as an ammonia adduct. Ammonia-free NI₃ was found to be isolable at –196 °C but spontaneously decomposes at 0 °C. For thermodynamic reasons related to electronegativity of the elements, neutral sulfur and selenium iodides that are stable at room temperature are also nonexistent, although S₂I₂ and SI₂ are stable up to 183 and 9 K, respectively. As of 2022, no neutral binary selenium iodide has been unambiguously identified (at any temperature). Sulfur- and selenium-iodine polyatomic cations (e.g., ₂ and ₂) have been prepared and characterised crystallographically.

Given the large size of the iodide anion and iodine's weak oxidising power, high oxidation states are difficult to achieve in binary iodides, the maximum known being in the pentaiodides of niobium, tantalum, and protactinium. Iodides can be made by reaction of an element or its oxide, hydroxide, or carbonate with hydroiodic acid, and then dehydrated by mildly high temperatures combined with either low pressure or anhydrous hydrogen iodide gas. These methods work best when the iodide product is stable to hydrolysis. Other syntheses include high-temperature oxidative iodination of the element with iodine or hydrogen iodide, high-temperature iodination of a metal oxide or other halide by iodine, a volatile metal halide, carbon tetraiodide, or an organic iodide. For example, molybdenum(IV) oxide reacts with aluminium(III) iodide at 230 °C to give molybdenum(II) iodide. An example involving halogen exchange is given below, involving the reaction of tantalum(V) chloride with excess aluminium(III) iodide at 400 °C to give tantalum(V) iodide:

$${\displaystyle {\ce {3TaCl5 + {\underset {(excess)}{5AlI3}}-> 3TaI5 + 5AlCl3}}}$$

Lower iodides may be produced either through thermal decomposition or disproportionation, or by reducing the higher iodide with hydrogen or a metal, for example:

$${\displaystyle {\ce {TaI5{}+Ta->Ta6I14}}}$$

Most metal iodides with the metal in low oxidation states (+1 to +3) are ionic. Nonmetals tend to form covalent molecular iodides, as do metals in high oxidation states from +3 and above. Both ionic and covalent iodides are known for metals in oxidation state +3 (e.g. scandium iodide is mostly ionic, but aluminium iodide is not). Ionic iodides MI_n tend to have the lowest melting and boiling points among the halides MX_n of the same element, because the electrostatic forces of attraction between the cations and anions are weakest for the large iodide anion. In contrast, covalent iodides tend to instead have the highest melting and boiling points among the halides of the same element, since iodine is the most polarisable of the halogens and, having the most electrons among them, can contribute the most to van der Waals forces. Naturally, exceptions abound in intermediate iodides where one trend gives way to the other. Similarly, solubilities in water of predominantly ionic iodides (e.g. potassium and calcium) are the greatest among ionic halides of that element, while those of covalent iodides (e.g. silver) are the lowest of that element. In particular, silver iodide is very insoluble in water and its formation is often used as a qualitative test for iodine.

Iodine halides

The halogens form many binary, diamagnetic interhalogen compounds with stoichiometries XY, XY₃, XY₅, and XY₇ (where X is heavier than Y), and iodine is no exception. Iodine forms all three possible diatomic interhalogens, a trifluoride and trichloride, as well as a pentafluoride and, exceptionally among the halogens, a heptafluoride. Numerous cationic and anionic derivatives are also characterised, such as the wine-red or bright orange compounds of ICl
₂ and the dark brown or purplish black compounds of I₂Cl. Apart from these, some pseudohalides are also known, such as cyanogen iodide (ICN), iodine thiocyanate (ISCN), and iodine azide (IN₃).

Iodine monofluoride (IF) is unstable at room temperature and disproportionates very readily and irreversibly to iodine and iodine pentafluoride, and thus cannot be obtained pure. It can be synthesised from the reaction of iodine with fluorine gas in trichlorofluoromethane at −45 °C, with iodine trifluoride in trichlorofluoromethane at −78 °C, or with silver(I) fluoride at 0 °C. Iodine monochloride (ICl) and iodine monobromide (IBr), on the other hand, are moderately stable. The former, a volatile red-brown compound, was discovered independently by Joseph Louis Gay-Lussac and Humphry Davy in 1813–1814 not long after the discoveries of chlorine and iodine, and it mimics the intermediate halogen bromine so well that Justus von Liebig was misled into mistaking bromine (which he had found) for iodine monochloride. Iodine monochloride and iodine monobromide may be prepared simply by reacting iodine with chlorine or bromine at room temperature and purified by fractional crystallisation. Both are quite reactive and attack even platinum and gold, though not boron, carbon, cadmium, lead, zirconium, niobium, molybdenum, and tungsten. Their reaction with organic compounds depends on conditions. Iodine chloride vapour tends to chlorinate phenol and salicylic acid, since when iodine chloride undergoes homolytic fission, chlorine and iodine are produced and the former is more reactive. However, iodine chloride in carbon tetrachloride solution results in iodination being the main reaction, since now heterolytic fission of the I–Cl bond occurs and I attacks phenol as an electrophile. However, iodine monobromide tends to brominate phenol even in carbon tetrachloride solution because it tends to dissociate into its elements in solution, and bromine is more reactive than iodine. When liquid, iodine monochloride and iodine monobromide dissociate into I
₂X
and IX
₂ ions (X = Cl, Br); thus they are significant conductors of electricity and can be used as ionising solvents.

Iodine trifluoride (IF₃) is an unstable yellow solid that decomposes above −28 °C. It is thus little-known. It is difficult to produce because fluorine gas would tend to oxidise iodine all the way to the pentafluoride; reaction at low temperature with xenon difluoride is necessary. Iodine trichloride, which exists in the solid state as the planar dimer I₂Cl₆, is a bright yellow solid, synthesised by reacting iodine with liquid chlorine at −80 °C; caution is necessary during purification because it easily dissociates to iodine monochloride and chlorine and hence can act as a strong chlorinating agent. Liquid iodine trichloride conducts electricity, possibly indicating dissociation to ICl
₂ and ICl
₄ ions.

Iodine pentafluoride (IF₅), a colourless, volatile liquid, is the most thermodynamically stable iodine fluoride, and can be made by reacting iodine with fluorine gas at room temperature. It is a fluorinating agent, but is mild enough to store in glass apparatus. Again, slight electrical conductivity is present in the liquid state because of dissociation to IF
₄ and IF
₆. The pentagonal bipyramidal iodine heptafluoride (IF₇) is an extremely powerful fluorinating agent, behind only chlorine trifluoride, chlorine pentafluoride, and bromine pentafluoride among the interhalogens: it reacts with almost all the elements even at low temperatures, fluorinates Pyrex glass to form iodine(VII) oxyfluoride (IOF₅), and sets carbon monoxide on fire.

Iodine oxides and oxoacids

Iodine oxides are the most stable of all the halogen oxides, because of the strong I–O bonds resulting from the large electronegativity difference between iodine and oxygen, and they have been known for the longest time. The stable, white, hygroscopic iodine pentoxide (I₂O₅) has been known since its formation in 1813 by Gay-Lussac and Davy. It is most easily made by the dehydration of iodic acid (HIO₃), of which it is the anhydride. It will quickly oxidise carbon monoxide completely to carbon dioxide at room temperature, and is thus a useful reagent in determining carbon monoxide concentration. It also oxidises nitrogen oxide, ethylene, and hydrogen sulfide. It reacts with sulfur trioxide and peroxydisulfuryl difluoride (S₂O₆F₂) to form salts of the iodyl cation, , and is reduced by concentrated sulfuric acid to iodosyl salts involving . It may be fluorinated by fluorine, bromine trifluoride, sulfur tetrafluoride, or chloryl fluoride, resulting iodine pentafluoride, which also reacts with iodine pentoxide, giving iodine(V) oxyfluoride, IOF₃. A few other less stable oxides are known, notably I₄O₉ and I₂O₄; their structures have not been determined, but reasonable guesses are I(IO₃)₃ and respectively.

More important are the four oxoacids: hypoiodous acid (HIO), iodous acid (HIO₂), iodic acid (HIO₃), and periodic acid (HIO₄ or H₅IO₆). When iodine dissolves in aqueous solution, the following reactions occur:

Hypoiodous acid is unstable to disproportionation. The hypoiodite ions thus formed disproportionate immediately to give iodide and iodate:

Iodous acid and iodite are even less stable and exist only as a fleeting intermediate in the oxidation of iodide to iodate, if at all. Iodates are by far the most important of these compounds, which can be made by oxidising alkali metal iodides with oxygen at 600 °C and high pressure, or by oxidising iodine with chlorates. Unlike chlorates, which disproportionate very slowly to form chloride and perchlorate, iodates are stable to disproportionation in both acidic and alkaline solutions. From these, salts of most metals can be obtained. Iodic acid is most easily made by oxidation of an aqueous iodine suspension by electrolysis or fuming nitric acid. Iodate has the weakest oxidising power of the halates, but reacts the quickest.

Many periodates are known, including not only the expected tetrahedral IO
₄, but also square-pyramidal IO
₅, octahedral orthoperiodate IO
₆, , , and I
₂O
₉. They are usually made by oxidising alkaline sodium iodate electrochemically (with lead(IV) oxide as the anode) or by chlorine gas:

They are thermodymically and kinetically powerful oxidising agents, quickly oxidising Mn to MnO
₄, and cleaving glycols, α-diketones, α-ketols, α-aminoalcohols, and α-diamines. Orthoperiodate especially stabilises high oxidation states among metals because of its very high negative charge of −5. Orthoperiodic acid, H₅IO₆, is stable, and dehydrates at 100 °C in a vacuum to Metaperiodic acid, HIO₄. Attempting to go further does not result in the nonexistent iodine heptoxide (I₂O₇), but rather iodine pentoxide and oxygen. Periodic acid may be protonated by sulfuric acid to give the I(OH)
₆ cation, isoelectronic to Te(OH)₆ and Sb(OH)
₆, and giving salts with bisulfate and sulfate.

Polyiodine compounds

When iodine dissolves in strong acids, such as fuming sulfuric acid, a bright blue paramagnetic solution including I
₂ cations is formed. A solid salt of the diiodine cation may be obtained by oxidising iodine with antimony pentafluoride:

The salt I₂Sb₂F₁₁ is dark blue, and the blue tantalum analogue I₂Ta₂F₁₁ is also known. Whereas the I–I bond length in I₂ is 267 pm, that in I
₂ is only 256 pm as the missing electron in the latter has been removed from an antibonding orbital, making the bond stronger and hence shorter. In fluorosulfuric acid solution, deep-blue I
₂ reversibly dimerises below −60 °C, forming red rectangular diamagnetic I
₄. Other polyiodine cations are not as well-characterised, including bent dark-brown or black I
₃ and centrosymmetric C_2h green or black I
₅, known in the AsF
₆ and AlCl
₄ salts among others.

The only important polyiodide anion in aqueous solution is linear triiodide, I
₃. Its formation explains why the solubility of iodine in water may be increased by the addition of potassium iodide solution:

Many other polyiodides may be found when solutions containing iodine and iodide crystallise, such as I
₅, I
₉, I
₄, and I
₈, whose salts with large, weakly polarising cations such as Cs may be isolated.

Organoiodine compounds

Organoiodine compounds have been fundamental in the development of organic synthesis, such as in the Hofmann elimination of amines, the Williamson ether synthesis, the Wurtz coupling reaction, and in Grignard reagents.

The carbon–iodine bond is a common functional group that forms part of core organic chemistry; formally, these compounds may be thought of as organic derivatives of the iodide anion. The simplest organoiodine compounds, alkyl iodides, may be synthesised by the reaction of alcohols with phosphorus triiodide; these may then be used in nucleophilic substitution reactions, or for preparing Grignard reagents. The C–I bond is the weakest of all the carbon–halogen bonds due to the minuscule difference in electronegativity between carbon (2.55) and iodine (2.66). As such, iodide is the best leaving group among the halogens, to such an extent that many organoiodine compounds turn yellow when stored over time due to decomposition into elemental iodine; as such, they are commonly used in organic synthesis, because of the easy formation and cleavage of the C–I bond. They are also significantly denser than the other organohalogen compounds thanks to the high atomic weight of iodine. A few organic oxidising agents like the iodanes contain iodine in a higher oxidation state than −1, such as 2-iodoxybenzoic acid, a common reagent for the oxidation of alcohols to aldehydes, and iodobenzene dichloride (PhICl₂), used for the selective chlorination of alkenes and alkynes. One of the more well-known uses of organoiodine compounds is the so-called iodoform test, where iodoform (CHI₃) is produced by the exhaustive iodination of a methyl ketone (or another compound capable of being oxidised to a methyl ketone), as follows:

Some drawbacks of using organoiodine compounds as compared to organochlorine or organobromine compounds is the greater expense and toxicity of the iodine derivatives, since iodine is expensive and organoiodine compounds are stronger alkylating agents. For example, iodoacetamide and iodoacetic acid denature proteins by irreversibly alkylating cysteine residues and preventing the reformation of disulfide linkages.

Halogen exchange to produce iodoalkanes by the Finkelstein reaction is slightly complicated by the fact that iodide is a better leaving group than chloride or bromide. The difference is nevertheless small enough that the reaction can be driven to completion by exploiting the differential solubility of halide salts, or by using a large excess of the halide salt. In the classic Finkelstein reaction, an alkyl chloride or an alkyl bromide is converted to an alkyl iodide by treatment with a solution of sodium iodide in acetone. Sodium iodide is soluble in acetone and sodium chloride and sodium bromide are not. The reaction is driven toward products by mass action due to the precipitation of the insoluble salt.

Occurrence and production

Iodine is the least abundant of the stable halogens, comprising only 0.46 parts per million of Earth's crustal rocks (compare: fluorine: 544 ppm, chlorine: 126 ppm, bromine: 2.5 ppm) making it the 60th most abundant element. Iodide minerals are rare, and most deposits that are concentrated enough for economical extraction are iodate minerals instead. Examples include lautarite, Ca(IO₃)₂, and dietzeite, 7Ca(IO₃)₂·8CaCrO₄. These are the minerals that occur as trace impurities in the caliche, found in Chile, whose main product is sodium nitrate. In total, they can contain at least 0.02% and at most 1% iodine by mass. Sodium iodate is extracted from the caliche and reduced to iodide by sodium bisulfite. This solution is then reacted with freshly extracted iodate, resulting in comproportionation to iodine, which may be filtered off.

The caliche was the main source of iodine in the 19th century and continues to be important today, replacing kelp (which is no longer an economically viable source), but in the late 20th century brines emerged as a comparable source. The Japanese Minami Kantō gas field east of Tokyo and the American Anadarko Basin gas field in northwest Oklahoma are the two largest such sources. The brine is hotter than 60 °C from the depth of the source. The brine is first purified and acidified using sulfuric acid, then the iodide present is oxidised to iodine with chlorine. An iodine solution is produced, but is dilute and must be concentrated. Air is blown into the solution to evaporate the iodine, which is passed into an absorbing tower, where sulfur dioxide reduces the iodine. The hydrogen iodide (HI) is reacted with chlorine to precipitate the iodine. After filtering and purification the iodine is packed.

These sources ensure that Chile and Japan are the largest producers of iodine today. Alternatively, the brine may be treated with silver nitrate to precipitate out iodine as silver iodide, which is then decomposed by reaction with iron to form metallic silver and a solution of iron(II) iodide. The iodine is then liberated by displacement with chlorine.

Applications

About half of all produced iodine goes into various organoiodine compounds, another 15% remains as the pure element, another 15% is used to form potassium iodide, and another 15% for other inorganic iodine compounds. Among the major uses of iodine compounds are catalysts, animal feed supplements, stabilisers, dyes, colourants and pigments, pharmaceutical, sanitation (from tincture of iodine), and photography; minor uses include smog inhibition, cloud seeding, and various uses in analytical chemistry.

X-ray imaging

As an element with high electron density and atomic number, iodine efficiently absorbs X-rays. X-ray radiocontrast agents is the top application for iodine. In this application, Organoiodine compounds are injected intravenously. This application is often in conjunction with advanced X-ray techniques such as angiography and CT scanning. At present, all water-soluble radiocontrast agents rely on iodine-containing compounds.

Iodine absorbs X-rays with energies lessthan 33.3 keV due to the photoelectric effect of the innermost electrons.

Biocide

Use of iodine as a biocide represents a major application of the element, ranked 2nd by weight. Elemental iodine (I) is used as an antiseptic in medicine. A number of water-soluble compounds, from triiodide (I₃, generated in situ by adding iodide to poorly water-soluble elemental iodine) to various iodophors, slowly decompose to release I when applied.

Optical polarising films

Thin-film-transistor liquid crystal displays rely on polarisation. The liquid crystal transistor is sandwiched between two polarising films and illuminated from behind. The two films prevent light transmission unless the transistor in the middle of the sandwich rotates the light. Iodine-impregnated polymer films are used in polarising optical components with the highest transmission and degree of polarisation.

Co-catalyst

Another significant use of iodine is as a cocatalyst for the production of acetic acid by the Monsanto and Cativa processes. In these technologies, hydroiodic acid converts the methanol feedstock into methyl iodide, which undergoes carbonylation. Hydrolysis of the resulting acetyl iodide regenerates hydroiodic acid and gives acetic acid. The majority of acetic acid is produced by these approaches.

Nutrition

Salts of iodide and iodate are used extensively in human and animal nutrition. This application reflects the status of iodide as an essential element, being required for two hormones. The production of ethylenediamine dihydroiodide, provided as a nutritional supplement for livestock, consumes a large portion of available iodine. Iodine is a component of iodised salt.

A saturated solution of potassium iodide is used to treat acute thyrotoxicosis. It is also used to block uptake of iodine-131 in the thyroid gland (see isotopes section above), when this isotope is used as part of radiopharmaceuticals (such as iobenguane) that are not targeted to the thyroid or thyroid-type tissues.

Others

Inorganic iodides find specialised uses. Titanium, zirconium, hafnium, and thorium are purified by the Van Arkel–de Boer process, which involves the reversible formation of the tetraiodides of these elements. Silver iodide is a major ingredient to traditional photographic film. Thousands of kilograms of silver iodide are used annually for cloud seeding to induce rain.

The organoiodine compound erythrosine is an important food colouring agent. Perfluoroalkyl iodides are precursors to important surfactants, such as perfluorooctanesulfonic acid.

I is used as the radiolabel in investigating which ligands go to which plant pattern recognition receptors (PRRs).

An iodine based thermochemical cycle has been evaluated for hydrogen production using energy from nuclear paper. The cycle has three steps. At 120 °C (248 °F), iodine reacts with sulfur dioxide and water to give hydrogen iodide and sulfuric acid:

${\displaystyle {\ce {I_{2}+SO_{2}+2H_{2}O\rightarrow 2HI+H_{2}SO_{4}}}}$

After a separation stage, at 830–850 °C (1,530–1,560 °F) sulfuric acid splits in sulfur dioxide and oxygen:

${\displaystyle {\ce {2H_{2}SO_{4}\rightarrow 2SO_{2}+2H_{2}O+O_{2}}}}$

Hydrogen iodide, at 300–320 °C (572–608 °F), gives hydrogen and the initial element, iodine:

${\displaystyle {\ce {2HI\rightarrow I_{2}+H_{2}}}}$

The yield of the cycle (ratio between lower heating value of the produced hydrogen and the consumed energy for its production, is approximately 38%. As of 2020, the cycle is not a competitive means of producing hydrogen.

Spectroscopy

The spectrum of the iodine molecule, I₂, consists of (not exclusively) tens of thousands of sharp spectral lines in the wavelength range 500–700 nm. It is therefore a commonly used wavelength reference (secondary standard). By measuring with a spectroscopic Doppler-free technique while focusing on one of these lines, the hyperfine structure of the iodine molecule reveals itself. A line is now resolved such that either 15 components (from even rotational quantum numbers, J_even), or 21 components (from odd rotational quantum numbers, J_odd) are measurable.

Caesium iodide and thallium-doped sodium iodide are used in crystal scintillators for the detection of gamma rays. The efficiency is high and energy dispersive spectroscopy is possible, but the resolution is rather poor.

Chemical analysis

The iodide and iodate anions can be used for quantitative volumetric analysis, for example in iodometry. Iodine and starch form a blue complex, and this reaction is often used to test for either starch or iodine and as an indicator in iodometry. The iodine test for starch is still used to detect counterfeit banknotes printed on starch-containing paper.

The iodine value is the mass of iodine in grams that is consumed by 100 grams of a chemical substance typically fats or oils. Iodine numbers are often used to determine the amount of unsaturation in fatty acids. This unsaturation is in the form of double bonds, which react with iodine compounds.

Potassium tetraiodomercurate(II), K₂HgI₄, is also known as Nessler's reagent. It is once was used as a sensitive spot test for ammonia. Similarly, Mayer's reagent (potassium tetraiodomercurate(II) solution) is used as a precipitating reagent to test for alkaloids. Aqueous alkaline iodine solution is used in the iodoform test for methyl ketones.

Biological role

Iodine is an essential element for life and, at atomic number Z = 53, is the heaviest element commonly needed by living organisms. (Lanthanum and the other lanthanides, as well as tungsten with Z = 74 and uranium with Z = 92, are used by a few microorganisms.) It is required for the synthesis of the growth-regulating thyroid hormones tetraiodothyronine and triiodothyronine (T₄ and T₃ respectively, named after their number of iodine atoms). A deficiency of iodine leads to decreased production of T₃ and T₄ and a concomitant enlargement of the thyroid tissue in an attempt to obtain more iodine, causing the disease goitre. The major form of thyroid hormone in the blood is tetraiodothyronine (T₄), which has a longer life than triiodothyronine (T₃). In humans, the ratio of T₄ to T₃ released into the blood is between 14:1 and 20:1. T₄ is converted to the active T₃ (three to four times more potent than T₄) within cells by deiodinases (5'-iodinase). These are further processed by decarboxylation and deiodination to produce iodothyronamine (T₁a) and thyronamine (T₀a'). All three isoforms of the deiodinases are selenium-containing enzymes; thus metallic selenium is needed for triiodothyronine and tetraiodothyronine production.

Iodine accounts for 65% of the molecular weight of T₄ and 59% of T₃. Fifteen to 20 mg of iodine is concentrated in thyroid tissue and hormones, but 70% of all iodine in the body is found in other tissues, including mammary glands, eyes, gastric mucosa, thymus, cerebrospinal fluid, choroid plexus, arteries, cervix, salivary glands. During pregnancy, the placenta is able to store and accumulate iodine. In the cells of those tissues, iodine enters directly by sodium-iodide symporter (NIS). The action of iodine in mammal tissues is related to fetal and neonatal development, and in the other tissues, it is known.

Dietary recommendations and intake

The daily levels of intake recommended by the United States National Academy of Medicine are between 110 and 130 μg for infants up to 12 months, 90 μg for children up to eight years, 130 μg for children up to 13 years, 150 μg for adults, 220 μg for pregnant women and 290 μg for lactating women. The Tolerable Upper Intake Level (TUIL) for adults is 1,100 μg/day. This upper limit was assessed by analysing the effect of supplementation on thyroid-stimulating hormone.

The European Food Safety Authority (EFSA) refers to the collective set of information as Dietary Reference Values, with Population Reference Intake (PRI) instead of RDA, and Average Requirement instead of EAR; AI and UL are defined the same as in the United States. For women and men ages 18 and older, the PRI for iodine is set at 150 μg/day; the PRI during pregnancy and lactation is 200 μg/day. For children aged 1–17 years, the PRI increases with age from 90 to 130 μg/day. These PRIs are comparable to the U.S. RDAs with the exception of that for lactation.

The thyroid gland needs 70 μg/day of iodine to synthesise the requisite daily amounts of T4 and T3. The higher recommended daily allowance levels of iodine seem necessary for optimal function of a number of body systems, including mammary glands, gastric mucosa, salivary glands, brain cells, choroid plexus, thymus, arteries.

Natural food sources of iodine include seafood which contains fish, seaweeds, kelp, shellfish and other foods which contain dairy products, eggs, meats, vegetables, so long as the animals ate iodine richly, and the plants are grown on iodine-rich soil. Iodised salt is fortified with potassium iodate, a salt of iodine, potassium, oxygen.

As of 2000, the median intake of iodine from food in the United States was 240 to 300 μg/day for men and 190 to 210 μg/day for women. The general US population has adequate iodine nutrition, with lactating women and pregnant women having a mild risk of deficiency. In Japan, consumption was considered much higher, ranging between 5,280 μg/day to 13,800 μg/day from wakame and kombu that are eaten, both in the form of kombu and wakame and kombu and wakame umami extracts for soup stock and potato chips. However, new studies suggest that Japan's consumption is closer to 1,000–3,000 μg/day. The adult UL in Japan was last revised to 3,000 μg/day in 2015.

After iodine fortification programs such as iodisation of salt have been done, some cases of iodine-induced hyperthyroidism have been observed (so-called Jod-Basedow phenomenon). The condition occurs mainly in people above 40 years of age, and the risk is higher when iodine deficiency is high and the first rise in iodine consumption is high.

Deficiency

In areas where there is little iodine in the diet, which are remote inland areas and faraway mountainous areas where no iodine rich foods are eaten, iodine deficiency gives rise to hypothyroidism, symptoms of which are extreme fatigue, goitre, mental slowing, depression, low weight gain, and low basal body temperatures. Iodine deficiency is the leading cause of preventable intellectual disability, a result that occurs primarily when babies or small children are rendered hypothyroidic by no iodine. The addition of iodine to salt has largely destroyed this problem in wealthier areas, but iodine deficiency remains a serious public health problem in poorer areas today. Iodine deficiency is also a problem in certain areas of all continents of the world. Information processing, fine motor skills, and visual problem solving are normalised by iodine repletion in iodine-deficient people.

Precautions

Toxicity

Iodine

Hazards
GHS labelling:
Pictograms
Signal word	Danger
Hazard statements	H312, H315, H319, H332, H335, H372, H400
Precautionary statements	P261, P273, P280, P305, P314, P338, P351
NFPA 704 (fire diamond)	3 0 0

Elemental iodine (I₂) is toxic if taken orally undiluted. The lethal dose for an adult human is 30 mg/kg, which is about 2.1–2.4 grams for a human weighing 70 to 80 kg (even when experiments on rats demonstrated that these animals could survive after eating a 14000 mg/kg dose and are still living after that). Excess iodine is more cytotoxic in the presence of selenium deficiency. Iodine supplementation in selenium-deficient populations is problematic for this reason. The toxicity derives from its oxidising properties, through which it denaturates proteins (including enzymes).

Elemental iodine is also a skin irritant. Solutions with high elemental iodine concentration, such as tincture of iodine and Lugol's solution, are capable of causing tissue damage if used in prolonged cleaning or antisepsis; similarly, liquid Povidone-iodine (Betadine) trapped against the skin resulted in chemical burns in some reported cases.

Occupational exposure

The U.S. Occupational Safety and Health Administration (OSHA) has set the legal limit (Permissible exposure limit) for iodine exposure in the workplace at 0.1 ppm (1 mg/m) during an 8-hour workday. The National Institute for Occupational Safety and Health (NIOSH) has set a Recommended exposure limit (REL) of 0.1 ppm (1 mg/m) during an 8-hour workday. At levels of 2 ppm, iodine is immediately dangerous to life and health.

Allergic reactions

Some people develop a hypersensitivity to products and foods containing iodine. Applications of tincture of iodine or Betadine can cause rashes, sometimes severe. Parenteral use of iodine-based contrast agents (see above) can cause reactions ranging from a mild rash to fatal anaphylaxis. Such reactions have led to the misconception (widely held, even among physicians) that some people are allergic to iodine itself; even allergies to iodine-rich foods have been so construed. In fact, there has never been a confirmed report of a true iodine allergy, as an allergy to iodine or iodine salts is biologically impossible. Hypersensitivity reactions to products and foods containing iodine are apparently related to their other molecular components; thus, a person who has demonstrated an allergy to one food or product containing iodine may not have an allergic reaction to another. Patients with various food allergies (fishes, shellfishes, eggs, milk, seaweeds, kelp, meats, vegetables, kombu, wakame) do not have an increased risk for a contrast medium hypersensitivity. The patient's allergy history is relevant.

US DEA List I status

Phosphorus reduces iodine to hydroiodic acid, which is a reagent effective for reducing ephedrine and pseudoephedrine to methamphetamine. For this reason, iodine was designated by the United States Drug Enforcement Administration as a List I precursor chemical under 21 CFR 1310.02.

Notes

1. The thermal expansion of crystalline iodine is anisotropic: the parameters (at 20 °C) for each axis are α_a = 86.5×10/K, α_b = 126×10/K, α_c = 12.3×10/K, and α_average = α_V/3 = 74.9×10/K.

References

1. "Standard Atomic Weights: Iodine". CIAAW. 1985.
2. Prohaska T, Irrgeher J, Benefield J, Böhlke JK, Chesson LA, Coplen TB, et al. (4 May 2022). "Standard atomic weights of the elements 2021 (IUPAC Technical Report)". Pure and Applied Chemistry. doi:10.1515/pac-2019-0603. ISSN 1365-3075.
3. ^ Arblaster JW (2018). Selected Values of the Crystallographic Properties of Elements. Materials Park, Ohio: ASM International. ISBN 978-1-62708-155-9.
4. I(II) is known to exist in monoxide (IO); see Nikitin IV (31 August 2008). "Halogen monoxides". Russian Chemical Reviews. 77 (8): 739–749. Bibcode:2008RuCRv..77..739N. doi:10.1070/RC2008v077n08ABEH003788. S2CID 250898175.
5. Magnetic susceptibility of the elements and inorganic compounds, in Handbook of Chemistry and Physics 81st edition, CRC press.
6. Weast R (1984). CRC, Handbook of Chemistry and Physics. Boca Raton, Florida: Chemical Rubber Company Publishing. pp. E110. ISBN 0-8493-0464-4.
7. ^ "Iodine". Micronutrient Information Center, Linus Pauling Institute, Oregon State University, Corvallis. 2015. Archived from the original on 17 April 2015. Retrieved 20 November 2017.
8. McNeil Jr DG (16 December 2006). "In Raising the World's I.Q., the Secret's in the Salt". The New York Times. Archived from the original on 12 July 2010. Retrieved 21 July 2009.
9. World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
10. ^ Courtois B (1813). "Découverte d'une substance nouvelle dans le Vareck" [Discovery of a new substance in seaweed]. Annales de chimie (in French). 88: 304–310. In French, seaweed that had been washed onto the shore was called "varec", "varech", or "vareck", whence the English word "wrack". Later, "varec" also referred to the ashes of such seaweed: the ashes were used as a source of iodine and salts of sodium and potassium.
11. Swain PA (2005). "Bernard Courtois (1777–1838) famed for discovering iodine (1811), and his life in Paris from 1798" (PDF). Bulletin for the History of Chemistry. 30 (2): 103. Archived from the original (PDF) on 14 July 2010. Retrieved 2 April 2009.
12. Greenwood and Earnshaw, p. 794
13. ^ "53 Iodine". Elements.vanderkrogt.net. Archived from the original on 23 January 2010. Retrieved 23 October 2016.
14. Desormes and Clément made their announcement at the Institut impérial de France on 29 November 1813; a summary of their announcement appeared in the Gazette nationale ou Le Moniteur Universel of 2 December 1813. See:
    • (Staff) (2 December 1813). "Institut Imperial de France". Le Moniteur Universel (in French) (336): 1344. Archived from the original on 28 November 2022. Retrieved 2 May 2021.
    • Chattaway FD (23 April 1909). "The discovery of iodine". Chemical News and Journal of Industrial Science. 99 (2578): 193–195.
15. ^ Gay-Lussac J (1813). "Sur un nouvel acide formé avec la substance décourverte par M. Courtois" [On a new acid formed by the substance discovered by Mr. Courtois]. Annales de Chimie (in French). 88: 311–318. Archived from the original on 19 March 2024. Retrieved 2 May 2021.
16. Gay-Lussac J (1813). "Sur la combination de l'iode avec d'oxigène" [On the combination of iodine with oxygen]. Annales de Chimie (in French). 88: 319–321. Archived from the original on 19 March 2024. Retrieved 2 May 2021.
17. Gay-Lussac J (1814). "Mémoire sur l'iode" [Memoir on iodine]. Annales de Chimie (in French). 91: 5–160.
18. Davy H (1813). "Sur la nouvelle substance découverte par M. Courtois, dans le sel de Vareck" [On the new substance discovered by Mr. Courtois in the salt of seaweed]. Annales de Chimie (in French). 88: 322–329. Archived from the original on 19 March 2024. Retrieved 2 May 2021.
19. Davy H (1 January 1814). "Some experiments and observations on a new substance which becomes a violet coloured gas by heat". Philosophical Transactions of the Royal Society of London. 104: 74–93. doi:10.1098/rstl.1814.0007.
20. Davaine C (1873). "Recherches relatives à l'action des substances dites antiseptiques sur le virus charbonneux" [Investigations regarding the action of so-called antiseptic substances on the anthrax bacterium]. Comptes rendus hebdomadaires des séances de l'Académie des Sciences (in French). 77: 821–825. Archived from the original on 5 May 2021. Retrieved 2 May 2021.
21. Grossich A (31 October 1908). "Eine neue Sterilisierungsmethode der Haut bei Operationen" [A new method of sterilization of the skin for operations]. Zentralblatt für Chirurgie (in German). 35 (44): 1289–1292. Archived from the original on 5 May 2021. Retrieved 2 May 2021.
22. "Mendeleev's First Periodic Table". web.lemoyne.edu. Archived from the original on 10 May 2021. Retrieved 25 January 2019.
23. ^ Greenwood and Earnshaw, pp. 800–4
24. Kugler HK, Keller C (1985). 'At, Astatine', System No. 8a. Gmelin Handbook of Inorganic and Organometallic Chemistry. Vol. 8 (8th ed.). Springer-Verlag. ISBN 978-3-540-93516-2.
25. ^ Greenwood and Earnshaw, pp. 804–9
26. Windholz, Martha, Budavari, Susan, Stroumtsos, Lorraine Y., Fertig, Margaret Noether, eds. (1976). Merck Index of Chemicals and Drugs (9th ed.). J A Majors Company. ISBN 978-0-911910-26-1.
27. ^ King RB (1995). Inorganic Chemistry of Main Group Elements. Wiley-VCH. pp. 173–98. ISBN 978-0-471-18602-1.
28. Stojanovska M, Petruševski VM, Šoptrajanov B (1 March 2012). "The concept of sublimation – iodine as an example". Educación Química. 23: 171–175. doi:10.1016/S0187-893X(17)30149-0. ISSN 0187-893X.
29. Li WK, Zhou GD, Mak TC (2008). Advanced Structural Inorganic Chemistry. Oxford University Press. p. 674. ISBN 978-0-19-921694-9.
30. ^ Audi G, Bersillon O, Blachot J, Wapstra AH (2003), "The NUBASE evaluation of nuclear and decay properties", Nuclear Physics A, 729: 3–128, Bibcode:2003NuPhA.729....3A, doi:10.1016/j.nuclphysa.2003.11.001
31. Reynolds JH (1 January 1960). "Determination of the Age of the Elements". Physical Review Letters. 4 (1): 8–10. Bibcode:1960PhRvL...4....8R. doi:10.1103/PhysRevLett.4.8. ISSN 0031-9007.
32. Manuel O (2002). "Origin of Elements in the Solar System". In Manuel O (ed.). Origin of Elements in the Solar System. Boston, MA: Springer US. pp. 589–643. doi:10.1007/0-306-46927-8_44. ISBN 978-0-306-46562-8.
33. Watson JT, Roe DK, Selenkow HA (September 1965). "Iodine-129 as a "nonradioactive" tracer". Radiation Research. 26 (1): 159–163. Bibcode:1965RadR...26..159W. doi:10.2307/3571805. JSTOR 3571805. PMID 4157487.
34. Snyder G, Fabryka-Martin J (2007). "I-129 and Cl-36 in dilute hydrocarbon waters: Marine-cosmogenic, in situ, and anthropogenic sources". Applied Geochemistry. 22 (3): 692–714. Bibcode:2007ApGC...22..692S. doi:10.1016/j.apgeochem.2006.12.011.
35. SCOPE 50 - Radioecology after Chernobyl Archived 13 May 2014 at the Wayback Machine, the Scientific Committee on Problems of the Environment (SCOPE), 1993. See table 1.9 in Section 1.4.5.2.
36. Hupf HB, Eldridge JS, Beaver JE (April 1968). "Production of iodine-123 for medical applications". The International Journal of Applied Radiation and Isotopes. 19 (4): 345–351. doi:10.1016/0020-708X(68)90178-6. PMID 5650883.
37. Harper, P.V.; Siemens, W.D.; Lathrop, K.A.; Brizel, H.E.; Harrison, R.W. Iodine-125. Proc. Japan Conf. Radioisotopes; Vol: 4 January 1, 1961
38. Rivkees SA, Sklar C, Freemark M (November 1998). "Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment". The Journal of Clinical Endocrinology and Metabolism. 83 (11): 3767–3776. doi:10.1210/jcem.83.11.5239. PMID 9814445.
39. Zanzonico PB, Becker DV (June 2000). "Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout". Health Physics. 78 (6): 660–667. doi:10.1097/00004032-200006000-00008. PMID 10832925. S2CID 30989865.
40. "Medical isotopes the likely cause of radiation in Ottawa waste". CBC News. 4 February 2009. Archived from the original on 19 November 2021. Retrieved 30 September 2015.
41. Moser H, Rauert W (2007). "Isotopic Tracers for Obtaining Hydrologic Parameters". In Aggarwal PK, Gat JR, Froehlich KF (eds.). Isotopes in the water cycle : past, present and future of a developing science. Dordrecht: Springer. p. 11. ISBN 978-1-4020-6671-9. Archived from the original on 19 March 2024. Retrieved 6 May 2012.
42. Rao SM (2006). "Radioisotopes of hydrological interest". Practical isotope hydrology. New Delhi: New India Publishing Agency. pp. 12–13. ISBN 978-81-89422-33-2. Archived from the original on 19 March 2024. Retrieved 6 May 2012.
43. "Investigating leaks in Dams & Reservoirs" (PDF). IAEA.org. Archived from the original (PDF) on 30 July 2013. Retrieved 6 May 2012.
44. Araguás LA, Bedmar AP (2002). "Artificial radioactive tracers". Detection and prevention of leaks from dams. Taylor & Francis. pp. 179–181. ISBN 978-90-5809-355-4. Archived from the original on 19 March 2024. Retrieved 6 May 2012.
45. Housecroft CE, Sharpe AG (2008). Inorganic Chemistry (3rd ed.). Prentice Hall. p. 541. ISBN 978-0-13-175553-6.
46. Greenwood and Earnshaw, pp. 806–07
47. Greenwood and Earnshaw, pp. 809–812
48. ^ Greenwood and Earnshaw, pp. 812–819
49. Holleman AF, Wiberg E (2001). Inorganic Chemistry. San Diego: Academic Press. ISBN 0-12-352651-5.
50. Jones JH (2000). "The Cativa Process for the Manufacture of Acetic Acid" (PDF). Platinum Metals Review. 44 (3): 94–105. doi:10.1595/003214000X44394105. Archived (PDF) from the original on 24 September 2015. Retrieved 26 August 2023.
51. Sunley GJ, Watsonv DJ (2000). "High productivity methanol carbonylation catalysis using iridium – The Cativa process for the manufacture of acetic acid". Catalysis Today. 58 (4): 293–307. doi:10.1016/S0920-5861(00)00263-7.
52. The ammonia adduct NI₃•NH₃ is more stable and can be isolated at room temperature as a notoriously shock-sensitive black solid.
53. Tornieporth-Oetting I, Klapötke T (June 1990). "Nitrogen Triiodide". Angewandte Chemie. 29 (6) (international ed.): 677–679. doi:10.1002/anie.199006771. ISSN 0570-0833. Archived from the original on 5 March 2023. Retrieved 5 March 2023.
54. Vilarrubias P (17 November 2022). "The elusive diiodosulphanes and diiodoselenanes". Molecular Physics. 120 (22): e2129106. Bibcode:2022MolPh.12029106V. doi:10.1080/00268976.2022.2129106. ISSN 0026-8976. S2CID 252744393. Archived from the original on 19 March 2024. Retrieved 5 March 2023.
55. Klapoetke T, Passmore J (1 July 1989). "Sulfur and selenium iodine compounds: from non-existence to significance". Accounts of Chemical Research. 22 (7): 234–240. doi:10.1021/ar00163a002. ISSN 0001-4842. Archived from the original on 15 January 2023. Retrieved 15 January 2023.
56. ^ Greenwood and Earnshaw, pp. 821–4
57. ^ Greenwood and Earnshaw, pp. 824–828
58. Greenwood and Earnshaw, pp. 828–831
59. Greenwood and Earnshaw, pp. 832–835
60. Greenwood and Earnshaw, pp. 851–853
61. ^ Greenwood and Earnshaw, pp. 853–9
62. Greenwood and Earnshaw, pp. 863–4
63. ^ Greenwood and Earnshaw, pp. 872–5
64. Greenwood and Earnshaw, pp. 842–4
65. Greenwood and Earnshaw, pp. 835–9
66. Hofmann AW (1851). "Beiträge zur Kenntniss der flüchtigen organischen Basen". Annalen der Chemie und Pharmacie. 78 (3): 253–286. doi:10.1002/jlac.18510780302. Archived from the original on 1 December 2022. Retrieved 30 June 2019.
67. Williamson A (1850). "Theory of Aetherification". Philosophical Magazine. 37 (251): 350–356. doi:10.1080/14786445008646627. Archived from the original on 9 November 2022. Retrieved 29 September 2020. (Link to excerpt. Archived 23 April 2019 at the Wayback Machine)
68. Wurtz A (1855). "Ueber eine neue Klasse organischer Radicale". Annalen der Chemie und Pharmacie. 96 (3): 364–375. doi:10.1002/jlac.18550960310. Archived from the original on 3 February 2023. Retrieved 30 June 2019.
69. Grignard V (1900). "Sur quelques nouvelles combinaisons organométaliques du magnésium et leur application à des synthèses d'alcools et d'hydrocabures". Comptes rendus de l'Académie des Sciences. 130: 1322–25. Archived from the original on 8 August 2019. Retrieved 2 October 2016.
70. Lyday PA. "Iodine and Iodine Compounds". Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. doi:10.1002/14356007.a14_381. ISBN 978-3527306732.
71. Blanksby SJ, Ellison GB (April 2003). "Bond dissociation energies of organic molecules" (PDF). Accounts of Chemical Research. 36 (4): 255–263. CiteSeerX 10.1.1.616.3043. doi:10.1021/ar020230d. PMID 12693923. Archived from the original (PDF) on 6 February 2009. Retrieved 25 October 2017.
72. Boeckman Jr RK, Shao P, Mullins JJ (2000). "Dess–Martin periodinane: 1,1,1-Triacetoxy-1,1-dihydro-1,2-benziodoxol-3(1H)-one" (PDF). Organic Syntheses. 77: 141; Collected Volumes, vol. 10, p. 696.
73. Jung ME, Parker MH (October 1997). "Synthesis of Several Naturally Occurring Polyhalogenated Monoterpenes of the Halomon Class(1)". The Journal of Organic Chemistry. 62 (21): 7094–7095. doi:10.1021/jo971371. PMID 11671809.
74. ^ Smith MB, March J (2007), Advanced Organic Chemistry: Reactions, Mechanisms, and Structure (6th ed.), New York: Wiley-Interscience, ISBN 978-0-471-72091-1
75. "Safety data for iodomethane". Oxford University. Archived from the original on 10 August 2010. Retrieved 12 December 2008.
76. Polgár L (August 1979). "Deuterium isotope effects on papain acylation. Evidence for lack of general base catalysis and for enzyme–leaving-group interaction". European Journal of Biochemistry. 98 (2): 369–374. doi:10.1111/j.1432-1033.1979.tb13196.x. PMID 488108.
77. Ervithayasuporn V, Ervithayasuporn V, Pornsamutsin N, Pornsamutsin N, Prangyoo P, Prangyoo P, et al. (October 2013). "One-pot synthesis of halogen exchanged silsesquioxanes: octakis(3-bromopropyl)octasilsesquioxane and octakis(3-iodopropyl)octasilsesquioxane". Dalton Transactions. 42 (37): 13747–13753. doi:10.1039/C3DT51373D. PMID 23907310. S2CID 41232118.
78. Streitwieser A (1956). "Solvolytic Displacement Reactions at Saturated Carbon Atoms". Chemical Reviews. 56 (4): 571–752. doi:10.1021/cr50010a001.
79. Bordwell FG, Brannen WT (1964). "The Effect of the Carbonyl and Related Groups on the Reactivity of Halides in S_N2 Reactions". Journal of the American Chemical Society. 86 (21): 4645–4650. doi:10.1021/ja01075a025.
80. ^ Greenwood and Earnshaw, pp. 795–796.
81. ^ Kogel JE, Trivedi NC, Barker JM, Krukowski ST, eds. (2006). Industrial Minerals & Rocks: Commodities, Markets, and Uses. SME. pp. 541–552. ISBN 978-0-87335-233-8.
82. Stanford EC (1862). "On the Economic Applications of Seaweed". Journal of the Society of Arts: 185–189.
83. Maekawa T, Igari SI, Kaneko N (2006). "Chemical and isotopic compositions of brines from dissolved-in-water type natural gas fields in Chiba, Japan". Geochemical Journal. 40 (5): 475. Bibcode:2006GeocJ..40..475M. doi:10.2343/geochemj.40.475.
84. Greenwood and Earnshaw, p. 799.
85. ^ Lyday PA, Kaiho T (2015). "Iodine and Iodine Compounds". Ullmann's Encyclopedia of Industrial Chemistry. Vol. A14. Weinheim: Wiley-VCH. pp. 382–390. doi:10.1002/14356007.a14_381.pub2. ISBN 978-3-527-30673-2.
86. Lancaster JL. "Chapter 4: Physical Determinants of Contrast" (PDF). Physics of Medical X-Ray Imaging. The University of Texas Health Science Center. Archived from the original (PDF) on 10 October 2015.
87. World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 499. hdl:10665/44053. ISBN 978-92-4-154765-9.
88. Block SS (2001). Disinfection, sterilization, and preservation. Hagerstwon, MD: Lippincott Williams & Wilkins. p. 159. ISBN 978-0-683-30740-5.
89. Ma J, Ye X, Jin B (1 April 2011). "Structure and application of polarizer film for thin-film-transistor liquid crystal displays". Displays. 32 (2): 49–57. doi:10.1016/j.displa.2010.12.006. ISSN 0141-9382.
90. Kahr B, Knowles KM (2014). "Polarizing Films". Iodine Chemistry and Applications. pp. 479–488. doi:10.1002/9781118909911.ch26. ISBN 978-1-118-46629-2.
91. Le Berre C, Serp P, Kalck, P, Torrence GP (2013). "Acetic Acid". Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. doi:10.1002/14356007.a01_045.pub3. ISBN 978-3527306732.
92. Sunley GJ, Watson DJ (26 May 2000). "High productivity methanol carbonylation catalysis using iridium: The Cativa™ process for the manufacture of acetic acid". Catalysis Today. 58 (4): 293–307. doi:10.1016/S0920-5861(00)00263-7. ISSN 0920-5861.
93. "Solubility of KI in water". Hazard.com. 21 April 1998. Archived from the original on 23 April 2012. Retrieved 21 January 2013.
94. "EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy" (PDF). 17 June 2009. Archived from the original (PDF) on 17 June 2009.
95. Boutrot F, Zipfel C (August 2017). "Function, Discovery, and Exploitation of Plant Pattern Recognition Receptors for Broad-Spectrum Disease Resistance". Annual Review of Phytopathology. 55 (1). Annual Reviews: 257–286. doi:10.1146/annurev-phyto-080614-120106. PMID 28617654.
96. ^ Corgnale C, Gorensek MB, Summers WA (November 2020). "Review of Sulfuric Acid Decomposition Processes for Sulfur-Based Thermochemical Hydrogen Production Cycles". Processes. 8 (11): 1383. doi:10.3390/pr8111383. ISSN 2227-9717.
97. Sansonetti CJ (August 1997). "Precise measurements of hyperfine components in the spectrum of molecular iodine". Journal of the Optical Society of America B. 14 (8): 1913–1920. doi:10.2172/464573. OSTI 464573. Archived from the original on 4 June 2021. Retrieved 11 January 2020.
98. Emsley J (2001). Nature's Building Blocks (Hardcover, First ed.). Oxford University Press. pp. 244–250. ISBN 978-0-19-850340-8.
99. Szász G, Buda L (1971). "Contribution to the reaction of alkaloids with potassium tetraiodomercurate". Fresenius' Zeitschrift für Analytische Chemie. 253 (5). Springer Science and Business Media LLC: 361–363. doi:10.1007/bf00426350. ISSN 0016-1152. S2CID 91439011.
100. Mornex, 1987 and Le Guen et al., 2000, cited by Le Guen B, Hemidy PY, Gonin M, Bailloeuil C, Van Boxsom D, Renier S, et al. (2001). "Arguments et retour d'expérience sur la distribution d'iode stable autour des centrales nucléaires françaises". Radioprotection. 36 (4): 417–430. doi:10.1051/radiopro:2001101.
101. Pol A, Barends TR, Dietl A, Khadem AF, Eygensteyn J, Jetten MS, et al. (January 2014). "Rare earth metals are essential for methanotrophic life in volcanic mudpots" (PDF). Environmental Microbiology. 16 (1): 255–264. Bibcode:2014EnvMi..16..255P. doi:10.1111/1462-2920.12249. PMID 24034209. Archived (PDF) from the original on 17 January 2024. Retrieved 17 January 2024.
102. Johnson JL, Rajagopalan KV, Mukund S, Adams MW. (5 March 1993). "Identification of molybdopterin as the organic component of the tungsten cofactor in four enzymes from hyperthermophilic Archaea". Journal of Biological Chemistry. 268 (7): 4848–52. doi:10.1016/S0021-9258(18)53474-8. PMID 8444863.{{cite journal}}: CS1 maint: multiple names: authors list (link)
103. Koribanics NM, Tuorto SJ, Lopez-Chiaffarelli N, McGuinness LR, Häggblom MM, Williams KH, et al. (2015). "Spatial distribution of an uranium-respiring betaproteobacterium at the Rifle, CO field research site". PLOS ONE. 10 (4): e0123378. Bibcode:2015PLoSO..1023378K. doi:10.1371/journal.pone.0123378. PMC 4395306. PMID 25874721.
104. Irizarry L (23 April 2014). "Thyroid Hormone Toxicity". Medscape. WedMD LLC. Archived from the original on 31 October 2021. Retrieved 2 May 2014.
105. Burns R, O'Herlihy C, Smyth PP (May 2011). "The placenta as a compensatory iodine storage organ". Thyroid. 21 (5): 541–6. doi:10.1089/thy.2010.0203. PMID 21417918.
106. Neven KY, Marien C, Janssen BG, Roels HA, Waegeneers N, Nawrot TS, et al. (13 January 2020). "Variability of iodine concentrations in the human placenta". Scientific Reports. 10 (1): 161. Bibcode:2020NatSR..10..161N. doi:10.1038/s41598-019-56775-3. PMC 6957482. PMID 31932629.
107. ^ Patrick L (June 2008). "Iodine: deficiency and therapeutic considerations" (PDF). Alternative Medicine Review. 13 (2): 116–127. PMID 18590348. Archived from the original (PDF) on 31 May 2013.
108. "Dietary Reference Intakes (DRIs): Recommended Intakes for Individuals, Vitamins". Institute of Medicine. 2004. Archived from the original on 30 October 2009. Retrieved 9 June 2010.
109. ^ United States National Research Council (2000). Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academies Press. pp. 258–259. doi:10.17226/10026. ISBN 978-0-309-07279-3. PMID 25057538. Archived from the original on 25 July 2015. Retrieved 9 March 2008.
110. "Overview on Dietary Reference Values for the EU population as derived by the EFSA Panel on Dietetic Products, Nutrition and Allergies" (PDF). 2017. Archived (PDF) from the original on 28 August 2017. Retrieved 3 December 2023.
111. Venturi S, Venturi M (September 2009). "Iodine, thymus, and immunity". Nutrition. 25 (9): 977–979. doi:10.1016/j.nut.2009.06.002. PMID 19647627.
112. Ullberg S, Ewaldsson B (February 1964). "Distribution of radio-iodine studied by whole-body autoradiography". Acta Radiologica. 2: 24–32. doi:10.3109/02841866409134127. PMID 14153759.
113. Venturi S (2014). "Iodine, PUFAs and Iodolipids in Health and Disease: An Evolutionary Perspective". Human Evolution. 29 (1–3): 185–205. ISSN 0393-9375.
114. "Where do we get iodine from?". Iodine Global Network. Archived from the original on 13 August 2015.
115. ^ "Iodine in diet". MedlinePlus Medical Encyclopedia. Archived from the original on 5 July 2016. Retrieved 7 April 2016.
116. "American Thyroid Association". thyroid.org. American Thyroid Association. Archived from the original on 3 August 2023. Retrieved 4 April 2014.
117. "Cerebos iodised table salt". Waitrose. 2023. Archived from the original on 28 March 2023. Retrieved 30 May 2023.
118. Caldwell KL, Makhmudov A, Ely E, Jones RL, Wang RY (April 2011). "Iodine status of the U.S. population, National Health and Nutrition Examination Survey, 2005–2006 and 2007–2008". Thyroid. 21 (4): 419–427. doi:10.1089/thy.2010.0077. PMID 21323596. Archived from the original on 2 December 2022. Retrieved 29 September 2020.
119. ^ Leung AM, Braverman LE, Pearce EN (November 2012). "History of U.S. iodine fortification and supplementation". Nutrients. 4 (11): 1740–1746. doi:10.3390/nu4111740. PMC 3509517. PMID 23201844.
120. Zava TT, Zava DT (October 2011). "Assessment of Japanese iodine intake based on seaweed consumption in Japan: A literature-based analysis". Thyroid Research. 4: 14. doi:10.1186/1756-6614-4-14. PMC 3204293. PMID 21975053.
121. "Overview of Dietary Reference Intakes for Japanese (2015)" (PDF). Minister of Health, Labour and Welfare, Japan. Archived (PDF) from the original on 23 April 2021. Retrieved 14 March 2022.
122. Wu T, Liu GJ, Li P, Clar C (2002). Wu T (ed.). "Iodised salt for preventing iodine deficiency disorders". The Cochrane Database of Systematic Reviews. 2010 (3): CD003204. doi:10.1002/14651858.CD003204. PMC 9006116. PMID 12137681.
123. Dissanayake CB, Chandrajith R, Tobschall HJ (1999). "The iodine cycle in the tropical environment – implications on iodine deficiency disorders". International Journal of Environmental Studies. 56 (3): 357. Bibcode:1999IJEnS..56..357D. doi:10.1080/00207239908711210.
124. Felig P, Frohman LA (2001). "Endemic Goiter". Endocrinology & metabolism. McGraw-Hill Professional. ISBN 978-0-07-022001-0. Archived from the original on 12 January 2023. Retrieved 29 September 2020.
125. "Micronutrient deficiency: iodine deficiency disorders". WHO. Archived from the original on 30 September 2006.
126. Zimmermann MB, Connolly K, Bozo M, Bridson J, Rohner F, Grimci L (January 2006). "Iodine supplementation improves cognition in iodine-deficient schoolchildren in Albania: a randomized, controlled, double-blind study". The American Journal of Clinical Nutrition. 83 (1): 108–114. doi:10.1093/ajcn/83.1.108. PMID 16400058.
127. "Iodine 207772". I2. Archived from the original on 19 March 2024. Retrieved 2 October 2018.
128. Technical data for Iodine Archived 20 May 2023 at the Wayback Machine. periodictable.com
129. Smyth PP (2003). "Role of iodine in antioxidant defence in thyroid and breast disease". BioFactors. 19 (3–4): 121–130. doi:10.1002/biof.5520190304. PMID 14757962. S2CID 7803619.
130. Yerkes C (2007). "Lecture 29: Protein Structure and Denaturation". chem.uiuc.edu. University of Illinois. Archived from the original on 31 March 2022. Retrieved 23 October 2016.
131. Lowe DO, Knowles SR, Weber EA, Railton CJ, Shear NH (November 2006). "Povidone-iodine-induced burn: case report and review of the literature". Pharmacotherapy. 26 (11): 1641–1645. doi:10.1592/phco.26.11.1641. PMID 17064209. S2CID 25708713.
132. "CDC - NIOSH Pocket Guide to Chemical Hazards - Iodine". cdc.gov. Archived from the original on 29 November 2022. Retrieved 6 November 2015.
133. DermNet New Zealand Trust, Iodine Archived 7 July 2016 at the Wayback Machine
134. Boehm I (August 2008). "Seafood allergy and radiocontrast media: are physicians propagating a myth?". The American Journal of Medicine. 121 (8): e19. doi:10.1016/j.amjmed.2008.03.035. PMID 18691465.
135. ^ UCSF Department of Radiology & Biomedical Imaging, Iodine Allergy and Contrast Administration Archived 9 April 2021 at the Wayback Machine
136. Lombardo P, Nairz K, Boehm I (July 2019). "Patients' safety and the "iodine allergy" - How should we manage patients with iodine allergy before they receive an iodinated contrast medium?". European Journal of Radiology. 116 (7): 150–151. doi:10.1016/j.ejrad.2019.05.002. PMID 31153557. S2CID 164898934.
137. Katelaris C (2009). "'Iodine Allergy' label is misleading". Australian Prescriber. 32 (5): 125–128. doi:10.18773/austprescr.2009.061.
138. Skinner HF (1990). "Methamphetamine synthesis via hydriodic acid/red phosphorus reduction of ephedrine". Forensic Science International. 48 (2): 123–134. doi:10.1016/0379-0738(90)90104-7.
139. "PART 1310 - Section 1310.02 Substances covered". Archived from the original on 17 October 2017. Retrieved 5 December 2019.

Bibliography

• Greenwood NN, Earnshaw A (1997). Chemistry of the Elements (2nd ed.). Butterworth-Heinemann. ISBN 978-0-08-037941-8.

• Chemistry
• Medicine

• Definitions from Wiktionary
• Media from Commons
• Quotations from Wikiquote
• Texts from Wikisource
• Textbooks from Wikibooks
• Resources from Wikiversity

• Iodine
• Chemical elements
• Halogens
• Reactive nonmetals
• Diatomic nonmetals
• Dietary minerals
• Oxidizing agents
• Gases with color
• Chemical elements with primitive orthorhombic structure